Practice Survey: Depression Screening in Pediatric Inflammatory Bowel Disease

Michele H Maddux1, Megan Drovetta2, Laura M Mackner3

  • 1From the Division of Gastroenterology, Hepatology, and Nutrition, University of Missouri-Kansas City School of Medicine, Children's Mercy-Kansas City, Kansas City, MO.

Insights

Pediatric inflammatory bowel disease (IBD) centers screen for depression annually in most patients aged 12-14 years using the PHQ-9. Interventions include psychotherapy referrals and psychosocial provider involvement.

Area of Science:

  • Pediatric Gastroenterology
  • Mental Health in Chronic Illness
  • Healthcare Quality Improvement

Background:

  • Depression screening practices in pediatric inflammatory bowel disease (IBD) care are not well-documented.
  • This study addresses the current state of depression screening within the ImproveCareNow Collaborative Network.

Purpose of the Study:

  • To summarize and analyze current depression screening practices in pediatric IBD centers.
  • To identify common screening tools, intervention strategies, and barriers to routine screening.

Main Methods:

  • An online survey was distributed to pediatric IBD providers across 79 IBD centers.
  • The survey collected data on current depression screening protocols and procedures.

Main Results:

  • Half of surveyed centers conduct annual depression screening, primarily for patients aged 12-14 years.
  • The Patient Health Questionnaire (PHQ-9) is the most frequently used screening tool.
  • Positive screens lead to psychotherapy referrals or immediate psychosocial provider consultation; suicidal ideation triggers emergency referrals or consultations.
  • Key barriers include insufficient personnel/resources, billing issues, and limited clinic time.

Conclusions:

  • Pediatric IBD centers are implementing depression screening and targeted interventions, involving psychosocial providers.
  • Understanding these screening efforts is crucial for advancing clinical care and improving patient outcomes in pediatric IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
384
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
214
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
331
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
185
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
245